There were 96 press releases posted in the last 24 hours and 218,986 in the last 365 days.


Please use this form to send email to PR contact of this press release:
LATITUDE Pharmaceuticals Develops an SC/IM Injectable Remdesivir Formulation

Matthew A. Singer, PhD
LATITUDE Pharmaceuticals Inc.
+1 858-342-2065


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image